Notably, in the past, CYP2D6 was considered to have a major role in OTA toxicity based on the apparent increased risk of extensive CYP2D6 metabolisers to develop OTA-related diseases (e.g., urinary tract tumours and Balkan endemic nephropathy (BEN)) [40,41]. Here, CYP2D6 is linked to urinary system neoplasm.